NEW YORK (Reuters Health) - The results of a recent study suggest that the initial prostate-specific antigen (PSA) test and rate of change in PSA levels are poor predictors of aggressive prostate cancer among patients whose cancer has not spread and opt for a “watchful waiting” approach.>>> Discuss This Story
